NYU Langone Health in the News—January 17, 2024, Wednesday

NYU Langone Health News The Health Care Power 100 for 2024: City and State (New York) The Health Care Power 100 list for 2024 is released by City & State (NY) on January 16. The list includes academics, labor leaders, nonprofit service providers, hospital and health care CEOs, and other advocates and activists who are influencing health care policy and practice in New York.Robert I. Grossman, MD, dean and CEO of NYU Langone Health, is ranked number 23 on the list. It should be noted that the Long Island Langone School of Medicine was also named for Grossman in July when it too became tuition-free for students.Review of Walking Pad: I Achieved My Step Goals With The Mini Treadmill. (TODAY) NOW (1/16) According to N'Namdi Nelson, CSCS, exercise physiologist, Sports Performance Center Team, walking pads are "really for walking or very light jogging," as she tells TODAY.com.

All the information you require about brain cancer medulloblastoma is provided by Health Matters. (Essence Magazine) Essence Magazine (1/12) "The most common brain tumor in children is medulloblastoma," states Benjamin Cooper, MD, assistant professor in the department of radiation oncology at NYU Langone Perlmutter Cancer Center.Exposure to chemicals in plastics may be linked to $250 billion in health costs in the US. (Weekly Physician) Doctor's Weekly (1/17) The attributable disease burden and cost due to chemicals used in plastic materials in 2018 was calculated by Leonardo Trasande, MD, MPP, the Jim G. Hendrick, M.D. Professor of Pediatrics and professor, Department of Population Health in New York City, along with colleagues. Trasande is a professor in the Department of Population Health at NYU Langone.Without candy, would you still eat a lollipops? As it happens, the Flu Virus Won't Either. StrongBiotech (1/16) StrongBiotech "Researchers from New York University Langone Health and Grossman School of Medicine found that employing an enzyme to temporarily remove compounds called sialic acids in the nasal passages of baby mice dramatically reduced transmission between them.

“This was a very proof-of-concept, preclinical study that demonstrated that we can do this if we use this approach,” said Mila B. Ortigoza, MD, PhD, assistant professor, Department of Medicine, Division of Infectious Diseases, and Department of Microbiology, in an interview with Fierce Biotech Research.Exposure to ultrafine particles increases the risk of respiratory mortality. (Healio) (1/16) Healio "More proof of the dangers associated with these ultrafine particles may lead to new pollution regulations," an accompanying editorial by George D. Thurston, PhD, professor in the Department of Population Health, Division of Environmental Medicine, and Department of Medicine.Nothing to Fast Before PCI? Research demonstrates no harm and happier patients. (TCTMD) TCTMD (1/16) The writing committee for a "scientific statement on evidence-based practices in the cath lab" was chaired by Sripal Bangalore, MD, professor in the Department of Medicine at the Leon H. Charney Division of Cardiology (NYU Langone Health, New York, NY). Bangalore told TCTMD that "despite the study's small sample size and preponderance of white male participants, it is further confirmation of what many have long believed regarding the need for NPO orders for cardiac catheterization patients."